Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

Figure 1

Expression profiles of AMACR as assessed by RT-PCR. A. Expression of AMACR in normal tissues including heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and PBMC. LNCaP, a prostate cancer cell line was used as a positive control for AMACR expression. B. Expression of AMACR in prostate cancer cell lines. Beta-actin expression was detected as an internal control. AMACR mRNA was detected in three prostate cancer cell lines (LNCaP, DU145 and PC-3). C. Expression of AMACR in cancer tissues and noncancerous tissues from surgical specimens of two prostate cancer cases.

Back to article page